Enhancing Chemotherapy Efficacy in Pten-Deficient Prostate Tumors by Activating the Senescence-Associated Antitumor Immunity

Cited by papers we hold 13

• Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma · 2023
  No notice
• Inflammation-Induced Tumorigenesis and Metastasis · 2021
  No notice
• When dormancy fuels tumour relapse · 2021
  No notice
• Cellular senescence in cancer: from mechanisms to detection · 2020
  No notice
• Sex differences in cancer mechanisms · 2020
  No notice
• cGAS-STING, an important pathway in cancer immunotherapy · 2020
  No notice
• Senescence‐associated tissue microenvironment promotes colon cancer formation through the secretory factor GDF15 · 2019
  No notice
• Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition · 2019
  No notice
• PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise? · 2019
  No notice
• Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment · 2019
  No notice
• Cold Tumors: A Therapeutic Challenge for Immunotherapy · 2019
  No notice
• The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1 · 2018
  No notice
• STAT3 regulated ARF expression suppresses prostate cancer metastasis · 2015
  Corrected

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.